Bowel nosode

Gout, a form of inflammatory arthritis, poses significant challenges in its management due to limited efficacy and adverse effects associated with conventional therapies. This study aimed to compare the effectiveness of Bacillus no.7, a probiotic agent, and individualized homeopathic medicine in the treatment of gout. A comparative interventional study was conducted on 46 patients diagnosed with gout, systematically assigned to two groups: Group A receiving individualized homeopathic medicine , Group B receiving Bacillus no. 7. ACR EULAR Criteria was utililized for screening the potential patients of gout.The primary outcome measures serum uric acid levels, assessed at baseline and follow-up visits over a period of 6 months. Secondary outcomes encompassed reduction in intensity of pain (using NPRS). Statistical analysis revealed significant improvements in pain intensity and serum uric acid levels in both intervention groups. However, significant difference was observed between Bacillus no.7 and individualized homeopathic medicine groups in terms of efficacy. Furthermore, both interventions demonstrated a favorable safety profile with minimal adverse effects. Overall, our findings suggests that individualized homeopathic medicine may offer promising alternative therapeutic options for managing gout as compared to Bacillus no.7, warranting further investigation into their mechanisms of action and long-term effects.[1][4]

Tinea corporis is no longer fungal infection but rather most stubborn clinical condition. Tinea corporis is common superficial infection of skin caused by dermatophytes. Tinea corporis is usually flat, itchy, circular rash with clearer skin in middle initially, later with raised border spreading radially with erythematous vesicular edges. It may expand with irregular circles giving this infection a layman terminology Ringworm. Aim and Objective: This study was aimed to see the efficacy of Morgan Pure a bowel nosode, as an Intercurrent remedy in treating Tinea Corporis in the age group of 5 to 50 years, and to improve the quality of life of patients. Materials and methods: Fourty five cases were selected based on inclusion criteria. The improvement in Quality of life, using Dermatological life quality index (DLQI) scale was studied before and after the treatment. Result:Significant improvement in DLQI was observed and verified using paired t test. Conclusion: The study has explored the potential of using Morgan pure, that can be used as an intercurrent in cases of Tinea corporis infection, which not only improved skin complaints but also the quality of life of the patients.